Reply by Authors

Affiliations

¹ Department of Urology, University of Iowa, Iowa City, Iowa.
² Department of Urology, University of Virginia, Charlottesville, Virginia.
³ Department of Biostatistics, University of Iowa, Iowa City, Iowa.
⁴ Uropartners, Gurnee, Illinois.
⁵ Department of Urology and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
⁶ Department of Urology, University of Kansas, Kansas City, Kansas.
⁷ Department of Urology, University of California, San Diego, San Diego, California.
⁸ Department of Urology, University of Minnesota, Minneapolis, Minnesota.
⁹ Division of Urology, University of Utah, Salt Lake City, Utah.
¹⁰ Division of Urology, Duke University, Durham, North Carolina.
¹¹ Department of Urology, University of Alberta, Edmonton, Alberta, Canada.
¹² Department of Urology, Lahey Hospital and Medical Center, Burlington, Massachusetts.
¹³ Spokane Urology, Spokane, Washington.
¹⁴ Department of Urology, New York University, New York, New York.

Bradley A Erickson et al. J Urol. 2025 Apr.

. 2025 Apr;213(4):522-523.

doi: 10.1097/JU.0000000000004410. Epub 2025 Mar 7.

¹ Department of Urology, University of Iowa, Iowa City, Iowa.
² Department of Urology, University of Virginia, Charlottesville, Virginia.
³ Department of Biostatistics, University of Iowa, Iowa City, Iowa.
⁴ Uropartners, Gurnee, Illinois.
⁵ Department of Urology and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
⁶ Department of Urology, University of Kansas, Kansas City, Kansas.
⁷ Department of Urology, University of California, San Diego, San Diego, California.
⁸ Department of Urology, University of Minnesota, Minneapolis, Minnesota.
⁹ Division of Urology, University of Utah, Salt Lake City, Utah.
¹⁰ Division of Urology, Duke University, Durham, North Carolina.
¹¹ Department of Urology, University of Alberta, Edmonton, Alberta, Canada.
¹² Department of Urology, Lahey Hospital and Medical Center, Burlington, Massachusetts.
¹³ Spokane Urology, Spokane, Washington.
¹⁴ Department of Urology, New York University, New York, New York.

No abstract available

Comment on

Editorial Comment.
Johnsen NV. Johnsen NV. J Urol. 2025 Apr;213(4):521. doi: 10.1097/JU.0000000000004390. Epub 2025 Jan 21. J Urol. 2025. PMID: 39836876 No abstract available.
Editorial Comment.
Elyaguov J. Elyaguov J. J Urol. 2025 Apr;213(4):521-522. doi: 10.1097/JU.0000000000004391. Epub 2025 Jan 21. J Urol. 2025. PMID: 39836894 No abstract available.
Development and Validation of the Length, Segment, and Etiology Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data From the Trauma and Urologic Reconstructive Network of Surgeons.
Erickson BA, Tuong MN, Zorn AN, Schlaepfer CH, Alsikafi NF, Breyer BN, Broghammer JA, Buckley JC, Elliott SP, Myers JB, Peterson AC, Rourke KF, Smith TG 3rd, Vanni AJ, Voelzke BB, Zhao LC. Erickson BA, et al. J Urol. 2025 Apr;213(4):512-523. doi: 10.1097/JU.0000000000004369. Epub 2024 Dec 9. J Urol. 2025. PMID: 39652884

1. Erickson BA, Tuong MN, Zorn AN, et al. Development and Validation of the Length, Segment, and Etiology (LSE) Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data from the Trauma and Urologic Reconstruction Network of Surgeons. J Urol. Dec 9 2024:101097JU0000000000004369. doi:10.1097/JU.0000000000004369 - DOI - PMC - PubMed
1. Erickson BA, Ghareeb GM. Definition of Successful Treatment and Optimal Follow-up after Urethral Reconstruction for Urethral Stricture Disease. Urol Clin North Am. Feb 2017;44(1):1–9. doi:10.1016/j.ucl.2016.08.001 - DOI - PubMed
1. <Add reference for JU-24–2205>
1. <Add reference for JU-24–2206>